What is the oligosaccharide sequence of the red blood cell membrane glycolipid that determines the ABO blood groups, and how is this sequence formed?

ABO Blood Group Oligosaccharide Sequences and Formation

The Oligosaccharide Sequences

The ABO blood group antigens are determined by specific terminal sugar sequences added to a common precursor called the H antigen, which consists of Fucose-Galactose-N-acetylglucosamine (Fuc-Gal-GlcNAc). 1, 2

Specific Sequences for Each Blood Type:

• Type A antigen: The complete sequence is Gal-GlcNAc-Gal(GalNAc)-Fuc, where N-acetylgalactosamine (GalNAc) is the terminal immunodominant sugar 3, 1

• Type B antigen: The sequence is Gal-GlcNAc-Gal(Gal)-Fuc, where galactose (Gal) is the terminal immunodominant sugar 1, 4

• Type O: Expresses only the H antigen precursor (Fuc-Gal-GlcNAc) without additional terminal sugars 2

• Type AB: Expresses both A and B terminal sequences 5

These oligosaccharides attach to membrane proteins (glycoproteins) or lipids (glycolipids) on red blood cell surfaces and endothelial cells 3, 5.

How the Sequences Are Formed

The Biosynthetic Pathway:

Formation occurs through sequential enzymatic addition of monosaccharides in the Golgi apparatus by specific glycosyltransferases encoded by the ABO gene. 1, 6, 5

Step-by-Step Formation Process:

1. H antigen synthesis: A fucosyltransferase (encoded by the H gene, independent of ABO) adds fucose to the precursor oligosaccharide, creating the H antigen substrate 2

2. A or B antigen completion:

   • A transferase (N-acetylgalactosaminyltransferase): Adds GalNAc from UDP-GalNAc donor to H antigen, creating A antigen 1, 4
   • B transferase (galactosyltransferase): Adds Gal from UDP-galactose donor to H antigen, creating B antigen 1, 4

Molecular Basis of Enzyme Specificity:

The A and B transferases differ by only four critical amino acid residues (at positions 176,235,266, and 268), with positions 266 and 268 being most crucial for donor sugar specificity 1, 6:

• A transferase: Contains Leu266 and Gly268
• B transferase: Contains Met266 and Ala268

The bulky side chains of methionine and alanine in B transferase prevent it from binding N-acetylgalactosamine, restricting it to galactose binding 1. These enzymes undergo conformational changes from "open" to "semi-closed" to "closed" states as they bind substrates, with the closed form stabilized by both UDP-sugar donor and H antigen acceptor binding 6.

Type O Formation:

Type O results from a frameshift mutation (base deletion) in the ABO gene that produces a truncated, non-functional enzyme incapable of adding terminal sugars, leaving only the H antigen expressed 1, 2.

Clinical Relevance:

The H antigen precursor-product relationship explains antibody formation: individuals lacking A antigen naturally produce anti-A antibodies, those lacking B produce anti-B, type O produces both, and type AB produces neither 5. This occurs because the immune system recognizes the absent antigens as foreign, though the exact mechanism remains debated between natural antibody formation, gut bacteria exposure, or glycosylation errors 5.